Reuters :: Health

Cervical cancer advances give hope to poor

LONDON (Reuters) - New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers said on Thursday. <p><a href="http://feeds.reuters.com/~a/reuters/healthNews?a=VXjfIC"><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=VXjfIC" border="0"></img></a></p><div class="feedflare"> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=zyykBK"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=zyykBK" border="0"></img></a> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=yoxYQk"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=yoxYQk" border="0"></img></a> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=GopjFk"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=GopjFk" border="0"></img></a> </div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/376973704" height="1" width="1"/>